货号:A444075 同义名: Hexyl 5-aminolevulinate hydrochloride;P-1206
Hexaminolevulinate HCl is a fluorescent agent which has been approved for cystoscopic detection of papillary bladder cancer.
规格 | 价格 | 会员价 | 库存 | 数量 | |||
---|---|---|---|---|---|---|---|
{[ item.pr_size ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_am, item.pr_size) ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_am, item.pr_size) ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_am, item.pr_size) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate) ]} | 现货 | 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解
描述 | Hexaminolevulinate HCl is a fluorescent agent which has been approved for cystoscopic detection of papillary bladder cancer[3]. Clinical trials have shown that hexaminolevulinate (HAL) fluorescence cystoscopy improves the detection of bladder tumors compared with standard white-light cystoscopy, resulting in more efficacious treatment[4]. Exogenous administration of hexaminolevulinate induces fluorescent protoporphyrin IX (PpIX) accumulation preferentially in cancer cells. In some of the incubation conditions tested, the addition of DFO (deferoxamine) with HAL significantly increased PpIX 21 fluorescence of adherent monolayer cancer cells, but this was never the case for cells in suspension[5]. Blue light cystoscopy (BLC) with hexaminolevulinate during transurethral resection of bladder cancer improves detection of non-muscle-invasive bladder cancer (NMIBC) and reduces recurrence rates[6]. |
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
NCT02800473 | Bladder Cancer | Not Applicable | Completed | - | France ... 展开 >> Institut de Cancerologie de Lorraine Vandoeuvre-les-Nancy, France, 54519 收起 << |
NCT02857634 | - | Completed | - | France ... 展开 >> Groupement des Hôpitaux de l'Institut Catholique de Lille Lomme, Nord, France, 59462 收起 << | |
NCT03058705 | Bladder Cancer | Not Applicable | Completed | - | United States, New York ... 展开 >> University of Rochester Medical Center Rochester, New York, United States, 14642 收起 << |
计算器 | ||||
存储液制备 | 1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
3.97mL 0.79mL 0.40mL |
19.86mL 3.97mL 1.99mL |
39.72mL 7.94mL 3.97mL |
CAS号 | 140898-91-5 |
分子式 | C11H22ClNO3 |
分子量 | 251.75 |
别名 | Hexyl 5-aminolevulinate hydrochloride;P-1206;Hexyl 5- aminolevulinate;5-Aminolevulinic Acid hexyl ester;Hexaminolevulinate (hydrochloride);5-Aminolevulinic acid hexyl ester hydrochloride;Hexaminolevulinate hydrochloride |
运输 | 蓝冰 |
存储条件 |
液体 -20°C:3-6个月-80°C:12个月 粉末 Inert atmosphere,Room Temperature |
溶解度 |
DMSO: 105 mg/mL(417.08 mM),注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO H2O: 100 mg/mL(397.22 mM),配合低频超声助溶 |
动物实验配方 |